Tirzepatide is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg and gradually increasing by 2.5 mg every 4 weeks as tolerated to a maintenance dose ranging from 5 mg to 15 mg, depending on individual response and tolerability
You may see little or no results and find yourself disappointed or, worse, lulled into a false sense of security
Lab testing, careful monitoring, and individualized dosing are standard, ensuring safety and effectiveness
The product is intended for scientific research and development purposes only
List JF, He H, Habener JF
While Metformin is not a weight loss medication, it can help address one of the underlying metabolic factors that contributes to weight gain in PCOS